T, S., & PM, M. (2024). Current advancement in the preclinical models used for the assessment of diabetic neuropathy. Naunyn-Schmiedeberg's archives of pharmacology, 397(5), 2727. https://doi.org/10.1007/s00210-023-02802-0
Chicago Style (17th ed.) CitationT, Saini, and Mazumder PM. "Current Advancement in the Preclinical Models Used for the Assessment of Diabetic Neuropathy." Naunyn-Schmiedeberg's Archives of Pharmacology 397, no. 5 (2024): 2727. https://doi.org/10.1007/s00210-023-02802-0.
MLA (9th ed.) CitationT, Saini, and Mazumder PM. "Current Advancement in the Preclinical Models Used for the Assessment of Diabetic Neuropathy." Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 397, no. 5, 2024, p. 2727, https://doi.org/10.1007/s00210-023-02802-0.